News and Updates

Discover how AI and digital health networks are breaking down barriers to clinical trials, improving patient recruitment, and accelerating medical research.

NeuroSense Therapeutics outlines its strategic goals for ALS research and PrimeC clinical development in a new update for investors and stakeholders.

Khartis Therapeutics launches with $95M to develop an oral pill for Thyroid Eye Disease, aiming to challenge existing biologic infusions with new tech.

Karyopharm reports Q2 2026 financial results, highlighting major strides toward an sNDA submission for a novel myelofibrosis treatment. Learn more.

Sagimet Biosciences confirms its Phase 3 trial for denifanstat is on track for 2026, marking a major step forward in treating MASH and metabolic disease.

Sumitomo Pharma has officially dosed the first patient in a Phase I/IIa trial for DSP-3077. Learn about the study's scope, safety goals, and clinical aims.

The FDA has released new guidance to broaden clinical trial eligibility for cancer patients, aiming to increase diversity and speed up drug development.

Kupando has commenced its first-in-human Phase 1 clinical trial. Discover the latest updates on this investigational therapy’s safety and development path.

Are high ROI claims in clinical trials ignoring site-level costs? Discover why sustainable infrastructure is essential for the future of drug development.

Nafamostat receives key KDIGO endorsement for CRRT as Talphera nears completion of the NEPHRO trial. Discover how this shift impacts ICU patient care.